Budapest, Hungary

Hajnalka Kompagne

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 12.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2005-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hajnalka Kompagne – Innovator in Cognitive Function Enhancement

Introduction

Hajnalka Kompagne is a notable inventor based in Budapest, Hungary, recognized for her expertise in the pharmaceutical field. With a total of two patents to her name, she has made significant contributions to the enhancement of cognitive functions and neuroprotection through her innovative research.

Latest Patents

Her latest inventions include a medicament for the enhancement of cognitive function and neuroprotection. This invention focuses on the use of a specific chemical compound, 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]isoxazole-3-yl)piperidin-1-yl]ethyl-amino}-2-methyl-3-(2H)pyridazinone, or its pharmaceutically acceptable salts, to treat or prevent neuronal death, mental decline, and various cognitive disorders like Parkinson's disease and memory disturbances.

Additionally, she has developed a patent for substituted alkylaminopyridazinone derivatives, which are also aimed at treating anxiolytic conditions and cognitive disorders. This innovative approach highlights her commitment to advancing pharmaceutical science for improved mental health.

Career Highlights

Hajnalka has worked with prominent organizations such as Egis Pharmaceuticals Plc and Egis Pharmaceuticals Public Limited Company, allowing her to apply her innovative ideas in real-world scenarios. Her work in these companies underscores her role in advancing drug development and addressing cognitive health issues through cutting-edge research.

Collaborations

Throughout her career, Hajnalka has collaborated with distinguished professionals, including Gyula Simig and József Barkóczy. These partnerships reflect her ability to work effectively in team settings to push the boundaries of pharmaceutical research and development.

Conclusion

Hajnalka Kompagne's contributions to cognitive enhancement and neuroprotection are commendable and exemplify the spirit of innovation in the medical field. Her groundbreaking patents and collaborative efforts continue to pave the way for advancements in the treatment of cognitive disorders, making her a significant figure in contemporary pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…